Efficacy and Safety of Trifluridine/Tipiracil in Patients With Metastatic Gastric Cancer and Gastrectomy

This subgroup analysis of a randomized clinical trial compares trifluridine/tipiracil treatment with placebo for progression-free and overall survival among patients with previously treated metastatic gastric or gastroesophageal junction cancer who had or had not undergone gastrectomy.

Read the full article here

Related Articles